Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway

Fig. 2

Effects of putative stem cell-selective candidate drugs on proliferation and apoptosis in HHUA cells. AC Effects of the candidate drugs on HHUA cell proliferation as determined by MTS assay (A), HHUA cell apoptosis was determined by annexin V-staining (B), and the percentage of HHUA-SP cells among all HHUA cells was determined by flow cytometric analysis. C Each bar indicates the mean ± SEM absorbance at 490 nm (A), the percentage of annexin V-positive cells (B), and the percentage of HHUA-SP cells among all HHUA cells C obtained from three independent experiments using three individual samples. *, P < 0.01, **, P < 0.02, and ***P < 0.05, versus DMSO control (Ctrl), based on Student’s t-test

Back to article page